|
Glycomine, raises $12M and a part o that budget will be dedicated to PMM2-CDG (CDG Type Ia) Studies. This company came to the 2nd World Conferene on CDG 2015, organized by The Portuguese Association for CDG (APCDG) and partners. Glycomine will also attent the 3rd World Conference on CDG 2017 in Leuven. We request all patient groups and professionals to share this information and to save the date for the 3rd World Conference on CDG 2017. Glycomine's press release is HERE. Learn more about these Breaking News! 
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
June 2017
Categories |
- About US
-
Research
- WP1 Executive Commitee
- WP2 CDG Diagnosis
- WP3 CDG Genetics
- WP4 Biology to guide CDG therapies >
- WP5 Systems Biology and Bioinformatics >
- WP6 Clinical & Therapeutic CDG research >
- WP7 CDG psychology and educational research >
- WP8 CDG Lobby and Representation >
- WP9 Communication & Dissemination >
- WP10 Donations and funds
- WP11 Collaborations & Open positions
- WP12 Advisory committee
- Resources
- EDUCATION
-
Awareness
- Community
- Events
- DONATE
- BLOG
RSS Feed
- About US
-
Research
- WP1 Executive Commitee
- WP2 CDG Diagnosis
- WP3 CDG Genetics
- WP4 Biology to guide CDG therapies >
- WP5 Systems Biology and Bioinformatics >
- WP6 Clinical & Therapeutic CDG research >
- WP7 CDG psychology and educational research >
- WP8 CDG Lobby and Representation >
- WP9 Communication & Dissemination >
- WP10 Donations and funds
- WP11 Collaborations & Open positions
- WP12 Advisory committee
- Resources
- EDUCATION
-
Awareness
- Community
- Events
- DONATE
- BLOG
